Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 May 2022 | Story Dr Nitha Ramnath | Photo istock

The Faculty of Economic and Management Sciences at the University of the Free State is pleased to announce its affiliation with the prestigious American-based Chartered Financial Analyst (CFA) Institute of Investment and Financial Professionals. The affiliation of the Bachelor of Commerce in Investment Management and Banking with the CFA programme demonstrates that the programme embeds a significant portion of the intensive CFA programme’s candidate body of knowledge (CBK) and standards of professional conduct. This reflects the rigour and value of our degree programme in the field of investment and portfolio management.  

“The affiliation signals to potential students, employers, and the marketplace that the UFS BCom Investment Management and Banking curriculum is closely tied to professional practice and is well-suited to prepare students for a brighter carrier in the investment field and better placed to sit for the CFA examinations,” says Dr Nico Keyser, the Head of the Department of Economics and Finance in the Faculty of Economic and Management Sciences at the UFS.
Through participation in this programme, the university is eligible to receive CFA programme student scholarships each year, thereby massively contributing to the much-needed skill set of well-grounded financial analysts who can take our financial sector to new heights.

According to Dr Keyser, aligning the UFS degree programme with the CFA curriculum will equip students with the expertise and real-world skills in investment analysis that will set them apart from other institutions and peers. “We encourage our students to pursue professional certification that distinguishes them in the market and enhances their job execution skills, innovation, and employability,” says Dr Keyser. 

The CFA programme is an international postgraduate, globally recognised professional designation offered by the American-based CFA Institute to investment and financial professionals. To become a CFA charter holder, candidates are required to pass three exam levels covering the fundamentals of investments tools, valuing assets, portfolio management and wealth planning, and acceptable work experience to obtain the Chartered Financial Analyst (CFA®) designation.   

The CFA Institute is the world's largest association of investment professionals. Members attain the prestigious designation of 'Chartered Financial Analyst', and many hold prominent roles in leading investment firms in financial centres worldwide. 

“Aligning our programme with the CFA code of ethics and standard of professional conduct sets us apart in terms of preparing graduates who are ethically grounded and ready to execute their duties in an ethical and professional manner, which is a major necessity in the financial analysis and investment field. The affiliation is part of our continued commitment to promoting the highest standards of ethics and professional excellence in our investment graduates, which is one of the tenets of the CFA curriculum in grounding investment professionals for better functioning capital markets,” adds Keyser.  


News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept